In China, a significant number of patients suffer from rheumatic and immune diseases. Early diagnosis and standardized treatment are essential to help patients regain a normal life as soon as possible. To advance clinical and basic research in the field of rheumatology and immunology, improve diagnostic and therapeutic standards, enhance the capabilities of rheumatology clinicians, and foster interdisciplinary collaboration, the Chengdu High-Tech Medical Association successfully held the fifth session of the Rheumatology and Immunology Series Conference and RA Precision Individualized Treatment Symposium online on December 17, 2025. The conference invited renowned experts in rheumatology and immunology to deliver specialized academic reports, focusing on classic cases and cutting-edge technologies in the field. Attendees engaged in academic discussions and exchanges, sharing new concepts, advancements, and information in current clinical rheumatology and immunology. All participants expressed that they benefited greatly from the event.